Search the Newsreel

TNDM6032036 Bond Profile — Key Metrics

This article provides a bond profile for Tandem Diabetes Care, Inc.'s TNDM6032036 bond, detailing its key metrics such as a 1.5% coupon rate, March 15, 2029 maturity date, and an outstanding amount of $316.25 million. It also includes information about the issuer, Tandem Diabetes …

Tandem Diabetes Care Inc (TNDM) Risk Assessment: Volatility, Financial Risk & Investment Risk

Tandem Diabetes Care Inc (TNDM) has a risk assessment score of 5.08, placing it 84th out of 199 in the Healthcare Equipment & Supplies industry. The company's beta of 1.59 indicates higher volatility compared to the S&P 500, suggesting it may outperform in bull …

Tandem Diabetes Care Inc (TNDM) Valuation: PE, PB & Fair Value Analysis

Tandem Diabetes Care Inc (TNDM) currently holds a valuation score of 7.08, placing it 148th out of 199 companies in the Healthcare Equipment & Supplies industry. Its P/E ratio stands at -14.19. The company has not yet disclosed relevant data for P/B, P/S, and …

TNDM|Tandem Diabetes Care Inc|Price:18.585|Chg%:+0.825

This article provides a comprehensive stock analysis of Tandem Diabetes Care Inc (TNDM) by TradingKey. It highlights the company's strong fundamentals, high growth potential, and fair valuation, despite a sideways trading pattern. The analysis also covers institutional ownership, analyst ratings, and a detailed breakdown …

Tandem Diabetes Care Inc (TNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Tandem Diabetes Care Inc (TNDM), focusing on its support and resistance levels, key indicators, and moving averages. TNDM's current price momentum score is 4.96, indicating a range-bound trading opportunity between 16.04 (support) and 20.51 (resistance). While indicators …

Tandem Diabetes Care (TNDM) Slid as Lower Beta Profile Lags in Risk On Market

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for "Meridian Small Cap Growth Fund". A copy of the letter can be downloaded here. The U.S. market saw a strong rally in the second quarter, fueled by easing geopolitical tensions, falling …

Tandem Diabetes Care (TNDM) Projected to Release Quarterly Earnings on Thursday

Tandem Diabetes Care Inc (TNDM) Financial Health: Profitability & Balance Sheet Analysis

Tandem Diabetes Care Inc (TNDM) currently holds a financial score of 6.97, placing it 116th out of 199 companies in the Healthcare Equipment & Supplies industry. The company's financial status is noted as weak, despite high operating efficiency and recent positive growth in revenue …

Tandem Diabetes Care Announces Upcoming Conference Presentation

Tandem Diabetes Care, Inc. announced that its management will present a company update at Canaccord Genuity’s 46th Annual Growth Conference. The presentation is scheduled for Tuesday, August 11, 2026, at 1:30 PM Eastern Time. A live webcast and archived recording will be available on …

UBS Adjusts Price Target on Tandem Diabetes Care to $18 From $22, Maintains Neutral Rating

UBS has lowered its price target for Tandem Diabetes Care (TNDM) from $22 to $18, while reiterating a neutral rating on the stock. This adjustment reflects an updated outlook from the financial firm regarding the company's valuation. Tandem Diabetes Care is a global insulin …

Tandem Diabetes Care to Webcast Aug. 11 Company Update

Tandem Diabetes Care (TNDM) Could Be 41% Undervalued As Pharmacy Expansion Lifts The Narrative

Tandem Diabetes Care (TNDM) is considered 41% undervalued with a fair value of $29.20 compared to its current price of $17.17. The optimistic outlook is driven by anticipated benefits from broader pharmacy channel expansion, which is expected to lower patient costs, increase pump adoption, …

Tandem Diabetes Care Inc (TNDM) Institutional Confidence

The institutional shareholding score for Tandem Diabetes Care Inc (TNDM) is 10.00, placing it first in its industry. Institutional shareholding proportion increased by 8.98% quarter-over-quarter to 128.74%. Bill Nygren | OAKMX is the largest institutional shareholder with 900.81K shares, increasing holdings by 209.09%.

Tandem Diabetes Care Inc (TNDM) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the major shareholders and institutional holdings of Tandem Diabetes Care Inc (TNDM). It lists key institutional investors like BlackRock, Sessa Capital, and Vanguard, along with their respective proportions. The report also provides a historical overview of institutional shareholding data from 2023Q4 …

Tandem Diabetes Care, Inc. Revenue Breakdown – NASDAQ:TNDM

What Tandem Diabetes Care (TNDM)'s CGM Expansion and New Tubeless Rival Mean For Shareholders

Tandem Diabetes Care (TNDM) recently expanded the compatibility of its t:slim X2 insulin pump with Abbott's FreeStyle Libre 3 Plus CGM in five European countries, aiming to boost international sales and attract more users. Simultaneously, a new competitor, Modular Medical, founded by Tandem's original …

Understanding the Setup: (TNDM) and Scalable Risk

This article analyzes Tandem Diabetes Care Inc. (NASDAQ: TNDM), highlighting a strong bullish sentiment across all time horizons. It identifies a mid-channel oscillation pattern and points to an exceptional 80.5:1 risk-reward short setup with a 24.3% downside target. The analysis provides specific trading strategies—Position …

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 60% Potential Upside with Robust Buy Ratings

Tandem Diabetes Care (TNDM) is attracting investor interest with its diabetes management solutions, despite a challenging market. Analysts show significant optimism, with a

Tandem Diabetes Care Inc (TNDM) Shares Surge 6.0% -- What GF Sco

Tandem Diabetes Care Inc (TNDM) shares rose 6.0% on July 20, 2026, with the stock currently trading at $18.10, which is significantly below its estimated fair value of $29.95, indicating it is undervalued. The company has a GF Score of 66/100, suggesting above-average performance, …

TNDM6032036 Bond Coupon Profile — Rate & Payments

This article provides a bond coupon profile for TNDM6032036, a Tandem Diabetes Care, Inc. bond with a 1.5% interest rate maturing on March 15, 2029. It details the current coupon rate, notes that the next interest payment is scheduled for September 15, 2026, and …

When Will Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Become Profitable?

This article analyzes Tandem Diabetes Care, Inc.'s path to profitability, focusing on analyst expectations for earnings and revenue growth. It highlights that analysts predict the company will become profitable by 2026, with significant revenue increases expected in the coming years. The analysis also touches …

Can Tandem Diabetes Care (TNDM) Turn Revenue Beats Into Durable Returns On Capital?

Tandem Diabetes Care (TNDM) reported strong Q1 revenue and beat earnings estimates, but despite operational gains, it continues to face profitability challenges and weakening returns on capital. The article questions whether past growth investments are paying off and if the company's automated insulin delivery …

Form 4 Tandem Diabetes Care Inc For: 17 July By Investing.com

This article reports on a Form 4 filing for Tandem Diabetes Care Inc. on July 17. The company's stock symbol is TNDM, and its share price experienced a 4.85% increase. The article provides minimal detail beyond the initial announcement.

Tandem Diabetes Care (TNDM) COO logs RSU vesting, 31,741 shares held after tax withholding

Tandem Diabetes Care's EVP & Chief Operating Officer, Jean-Claude Kyrillos, reported the vesting of 3,636 restricted stock units (RSUs) on July 15, 2026, which converted into common stock. The company withheld 1,926 shares at $15.28 each to cover tax obligations, with no shares sold …

US875372AE4 Bond Profile — Key Metrics

This article provides key metrics for the Tandem Diabetes Care, Inc. bond with ISIN US875372AE4, maturing on March 15, 2032. It details the issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate as 0%. Additionally, it offers a brief …

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Boston Scientific (BSX)

RBC Capital maintained a Buy rating on Tandem Diabetes Care (TNDM) with a price target of $30.00. TD Cowen maintained a Buy rating on Boston Scientific (BSX) with a price target of $61.00, while the general analyst consensus for Boston Scientific is a Strong …

Why Tandem Diabetes (TNDM) Shares Are Sliding Today

Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now

TNDM Stock Down Following Q1 Earnings & Revenue Beat, Gross Margin Up

How Investors Are Reacting To Tandem Diabetes Care (TNDM) Expanding Control-IQ+ Use To Type 1 Pregnancies

Is It Time To Revisit Tandem Diabetes Care (TNDM) After Recent Share Price Weakness?

Tandem Diabetes schedules May 7 earnings call, webcast at 4:30 p.m. ET

TNDM Q4 Earnings & Revenues Beat Estimates, Gross Margin & Stock Up